🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 64125C109
- Market Cap
- Large Cap · $8 Billion
Business: Neurocrine Biosciences, Inc. a San Diego based biopharmaceutical company, is focused on developing treatments for neurological and endocrine related disorders. The company discovered, developed and markets INGREZZA® (valbenazine) capsules, the first FDA-approved product indicated for the treatment of adults with tardive dyskinesia, an involuntary movement disorder.
Company Contact
- CEO
- Kevin C. Gorman Ph.D.
- CFO
- Matthew C. Abernethy
- Headquarters
- 12780 El Camino Real, San Diego, CA 92130
- Phone
- 858-617-7600
- Fax
- 858-617-7601
- Investor Relations
- Navjot Rai · 858-617-7600 · ir@neurocrine.com